India to Australia: Roxithromycin Export Trade Route

The India to Australia Roxithromycin corridor is one of India's established pharmaceutical export routes, with 54 shipments documented worth a combined $758.8K USD. The route is dominated by STRIDES PHARMA SCIENCE LIMITED, which alone accounts for roughly 77% of all export value, reflecting the consolidated nature of India's roxithromycin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $14.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with roxithromycin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 18.2%, placing it at rank #19 among India's top roxithromycin export destinations globally.

On the import side, key buyers of Indian roxithromycin in Australia include ARROW PHARMACEUTICALS PTY LTD,, APOTEX PTY LTD.,, APOTEX PTY LTD., and 10 others. ARROW PHARMACEUTICALS PTY LTD, is the single largest importer with 10 shipments valued at $150.2K USD.

India's roxithromycin exports to Australia are driven primarily by a handful of large-scale manufacturers. STRIDES PHARMA SCIENCE LIMITED with 41 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STRIDES PHARMA SCIENCE LIMITED, STRIDES PHARMA SCIENCE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $14.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as roxar 150 roxithromycin tablets 150mg (61620 x 1 x 10s) and roxithromycin-wgr roxithromycin tablets300mg 67,350.00x 1x5's, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ARROW PHARMACEUTICALS PTY LTD, is the largest importer with 10 shipments worth $150.2K USD — representing 20% of all roxithromycin imports from India on this route. A total of 13 buyers are active on this corridor.